Aurinia Pharmaceuticals Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Aurinia Pharmaceuticals Inc., a foreign private issuer, on July 29, 2016. The filing serves to incorporate a Material Change Report dated July 29, 2016, by reference into the company's Registration Statement on Form F-10 (File No. 333-206994).
Financial Metrics
The provided filing text does not contain specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document.
Material Changes
The filing references a Material Change Report (Exhibit 99.1) but does not detail the specific nature of the change within the text of the Form 6-K itself.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It strictly serves as a procedural vehicle to incorporate the referenced Material Change Report.
Key Facts for Investor Verification
- Verify the specific details of the Material Change by reviewing Exhibit 99.1, which is incorporated by reference but not included in the provided text.
- Confirm the status of the Registration Statement on Form F-10 (File No. 333-206994) to understand the context of this incorporation.
- Note that this document contains no standalone financial performance data for the period ending July 29, 2016.